Swine Flu Stock Rundown
Fears about the swine flu outbreak, which has caused over 100 deaths in Mexico and at least 40 cases in the U.S., is having widespread implications on various stocks today. Click here for the full report. Below is a rundown:
Negative Implications:
1. Food Stocks: Pork processors getting hurt on fears people will buy less pork. Smithfield Foods said it has found no clinical signs or symptoms of the presence of swine influenza in the company's swine herd or its employees at its joint ventures in Mexico.
- Tyson Foods Inc. (NYSE: TSN) -7%
- Smithfield Foods Inc. (NYSE: SFD) -12%
- Zhongpin, Inc. (Nasdaq: HOGS) -7%
2. Travel Stocks: Travel stocks are getting hurt on concerns that people will cut down on travel and cancel trips due to fears of the swine flu.
- Royal Caribbean Cruises Ltd. (NYSE: RCL) -13%
- Carnival Corp. (NYSE: CCL) -10%
- UAL Corporation (Nasdaq: UAUA) -12%
- US Airways Group, Inc. (NYSE: LCC) -16%
- Southwest Airlines Co. (NYSE: LUV) -9%
- JetBlue Airways Corporation (Nasdaq: JBLU) -7%
- Continental Airlines, Inc. (NYSE: CAL) -11%
- Delta Air Lines Inc. (NYSE: DAL) -12%
- China Southern Airlines Co. Ltd. (NYSE: ZNH) -14%
- China Eastern Airlines Corp. Ltd. (NYSE: CEA) -8%
- Claymore/NYSE Arca Airline (NYSE: FAA) -11%
- iShares MSCI Mexico Investable Mkt Idx (NYSE: EWW) -6%
- Mexico Fund (NYSE: MXF) -6%
- Grupo Aeroportuario Del Sureste SA de CV (NYSE: ASR) -13%
- Grupo Aeroportuario del Pacifico S.A.B. de CV (NYSE: PAC) -15%
- America Movil S.A.B. de C.V. (NYSE: AMX) -7.5%
- CEMEX, S.A.B. de C.V. (NYSE: CX) -6%
Positive Implications:
1. Flu Treatment Stocks: Officals said the ilness is reacting to some currnent treatements, TAMIFLU and Relenza:
- Gilead Sciences' (Nasdaq: GILD) +3.5%; makes royalties on TAMIFLU from Roche
- GlaxoSmithKline (NYSE: GSK) +7%; markets Biota's Relenza.
2. Flu Prevention Products: Product used to prevent the spread of the swine flu.
- Alpha Pro Tech (AMEX: APT) +34%; masks
- Pure Bioscience (Nasdaq: PURE) +50%; disinfectants
- Quidel Corp. (Nasdaq: QDEL) +5%; point-of-care flu tests
3. Speculative Treatment Stocks: Speculation of new vaccine or treatment
- Novavax, Inc. (Nasdaq: NVAX) +105%
- AVI BioPharma (Nasdaq: AVII) +16%
- BioCryst Pharmaceuticals (Nasdaq: BCRX) +80%
- Sinovac Biotech (AMEX: SVA) +34%
- Hemispherx BioPharma (AMEX: HEB) +29%
- Generex Biotechnology (Nasdaq: GNBT) +48%
- Crucell NV (Nasdaq: CRXL) +8%
- Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) +12%
- Celldex Therapeutics, Inc. (Nasdaq: CLDX) +5%
- Luminex Corporation (Nasdaq: LMNX) +3%
- Vical Inc. (Nasdaq: VICL) +14%
4. Drug Stores Stocks: Hopes people will stock-up on therapies and preventative items:
5. Blood Supply Stocks: Fears blood supplies could be tarnished by the illness:
- Cerus Corporation (Nasdaq: CERS) +19%
Get Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
Insiders' BlogMomentum Movers
Trader Talk
Stocks Mentioned
Related Entities
Comments
3M's New Flu Test
I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

ASFX has a swine flu product
relaxed137 on Jun 14, 2009 05:38 PMASFX.pk sells the thermofocus at walgreens and babies-r-us. It's a no-touch thermometer and orders are going through the roof. Buy one for yourself so you can take temperatures with out getting the swine flu! http://finance.yahoo.com/news/Safety-Product-Company-Sees-prnews-15504232.html?.v=1 This thermometer (Thermofocus) was used heavily in ASIA during SARS